ACCF/AHA clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons

J Am Coll Cardiol. 2010 Jul 20;56(4):321-41. doi: 10.1016/j.jacc.2010.05.013.

Authors

David R Holmes Jr, Gregory J Dehmer, Sanjay Kaul, Dana Leifer, Patrick T O'Gara, C Michael Stein

PMID: 20633831
DOI: 10.1016/j.jacc.2010.05.013

No abstract available

Publication types

Consensus Development Conference
Review

MeSH terms

Advisory Committees / standards*
American Heart Association*
Aryl Hydrocarbon Hydroxylases / genetics
Aryl Hydrocarbon Hydroxylases / metabolism
Cardiology / standards
Clopidogrel
Coronary Angiography / standards
Cytochrome P-450 CYP2C19
Drug Labeling / methods
Drug Labeling / standards*
Foundations / standards
Humans
Societies, Medical / standards*
Thoracic Surgery / standards
Ticlopidine / adverse effects
Ticlopidine / analogs & derivatives*
Ticlopidine / metabolism
United States
United States Food and Drug Administration* / standards

Substances

Clopidogrel
Aryl Hydrocarbon Hydroxylases
CYP2C19 protein, human
Cytochrome P-450 CYP2C19
Ticlopidine